U.S. Markets closed

BIOLASE Completes Sale of Last WaterLase MD Turbo Laser Systems Repurchased From Schein

IRVINE, CA--(Marketwire - Jan 8, 2013) - BIOLASE, Inc. ( NASDAQ : BIOL ), the world's leading dental laser manufacturer and distributor, announced today that the Company has sold the last of the 159 WaterLase® MD Turbo™ laser systems it repurchased earlier this year from Henry Schein, Inc. ( NASDAQ : HSIC ) ("Schein"). 

The Company had initially planned to use a portion of the purchased Schein inventory as a source of parts to service its large installed base of MD Turbo laser systems. However, due to the high demand for the equipment, all of the re-purchased laser systems were ultimately sold. BIOLASE repurchased the units from Schein at a very advantageous price under a February 2012 agreement and sold them throughout the last three quarters at margins consistent with its other laser products.

Federico Pignatelli, Chairman and CEO of BIOLASE, said, "The strong demand for these WaterLase MD Turbo laser systems over the past three quarters along with a period of consistent growth in the direct sales of our flagship WaterLase iPlus™ to end users in North America, demonstrate the benefits and effectiveness of having a wide range of WaterLase products."

About WaterLase
BIOLASE's patented WaterLase technology combines its proprietary 2,780nm YSGG laser energy, air, and water that all emanate from its patented hand piece to symbiotically excite water molecules from within both the spray and the target tissue. This results in a biological ablation of both hard- and soft-tissue. Currently, BIOLASE offers several variations of WaterLase laser systems, including the flagship iPlus, the mid-priced MDX™ 450 and 300, and lower priced certified pre-owned MD Turbos.

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biological treatment and clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment and CAD/CAM systems. BIOLASE has sold more than 21,000 lasers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.